Early Alterations in Gene Expression and Cell Morphology in a Mouse Model of Huntington's Disease

Several mouse models for Huntington's disease (HD) have been produced to date. Based on differences in strain, promoter, construct, and number of glutamines, these models have provided a broad spectrum of neurological symptoms, ranging from simple increases in aggressiveness with no signs of ne...

Full description

Saved in:
Bibliographic Details
Published inJournal of neurochemistry Vol. 75; no. 2; pp. 830 - 839
Main Authors Iannicola, C, Moreno, S, Oliverio, S, Nardacci, R, Ciofi‐Luzzatto, A, Piacentini, M
Format Journal Article
LanguageEnglish
Published Oxford UK Blackwell Science Ltd 01.08.2000
Blackwell
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Several mouse models for Huntington's disease (HD) have been produced to date. Based on differences in strain, promoter, construct, and number of glutamines, these models have provided a broad spectrum of neurological symptoms, ranging from simple increases in aggressiveness with no signs of neuropathology, to tremors and seizures in absence of degeneration, to neurological symptoms in the presence of gliosis and TUNEL (terminal deoxynucleotidyl transferase‐mediated dUTP nick end‐labeling) positivity, and finally to selective striatal damage associated with electrophysiological and behavioral abnormalities. We decided to analyze the morphology of striatum and hippocampus from a mouse transgenic line obtained by microinjection of exon 1 from the HD gene after introduction of a very high number of CAG repeat units. We found a massive darkening and compacting of striatal and hippocampal neurons in affected mice, associated with a lower degree of more classical apoptotic cell condensation. We then explored whether this morphology could be explained with alterations in gene expression by hybridizing normal and affected total brain RNA to a panel of 588 known mouse cDNAs. We show that some genes are significantly and consistently up‐regulated and that others are down‐regulated in the affected brains. Here we discuss the possible significance of these alterations in neuronal morphology and gene expression.
Bibliography:Drs. A. Ciofi‐Luzzatto and M. Piacentini contributed equally to this work.
HD, Huntington's disease ; LR White, London Resin White ; NII, neuronal intranuclear inclusion ; PKC, protein kinase C ; SSC, saline‐sodium citrate ; Topo2, topoisomerase II ; TTF, transcription termination factor.
Abbreviations used
ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-1
content type line 23
ObjectType-Article-1
ObjectType-Feature-2
ISSN:0022-3042
1471-4159
DOI:10.1046/j.1471-4159.2000.0750830.x